AU2003283597A1 - Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors - Google Patents
Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitorsInfo
- Publication number
- AU2003283597A1 AU2003283597A1 AU2003283597A AU2003283597A AU2003283597A1 AU 2003283597 A1 AU2003283597 A1 AU 2003283597A1 AU 2003283597 A AU2003283597 A AU 2003283597A AU 2003283597 A AU2003283597 A AU 2003283597A AU 2003283597 A1 AU2003283597 A1 AU 2003283597A1
- Authority
- AU
- Australia
- Prior art keywords
- benzthiazole
- benzoxazole
- acid derivatives
- heparanase inhibitors
- benzimidazole acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0226820A GB0226820D0 (en) | 2002-11-16 | 2002-11-16 | Novel compounds |
GB0226820.9 | 2002-11-16 | ||
GB0319542A GB0319542D0 (en) | 2003-08-20 | 2003-08-20 | Novel compounds |
GB0319542.7 | 2003-08-20 | ||
PCT/GB2003/004991 WO2004046122A2 (en) | 2002-11-16 | 2003-11-17 | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003283597A1 true AU2003283597A1 (en) | 2004-06-15 |
AU2003283597A8 AU2003283597A8 (en) | 2004-06-15 |
Family
ID=32328067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003283597A Abandoned AU2003283597A1 (en) | 2002-11-16 | 2003-11-17 | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003283597A1 (en) |
WO (1) | WO2004046122A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006044682A1 (en) * | 2004-10-13 | 2006-04-27 | Ptc Therapeutics, Inc. | Compounds for nonsense suppression, and methods for their use |
EP1688413A1 (en) * | 2005-02-03 | 2006-08-09 | Hikma Pharmaceuticals Co. Ltd. | Benzoxazole derivatives for the prophylaxis and treatment of inflammatory bowel diseases |
WO2006094236A1 (en) * | 2005-03-03 | 2006-09-08 | Sirtris Pharmaceuticals, Inc. | N-phenyl benzamide derivatives as sirtuin modulators |
WO2007042816A1 (en) * | 2005-10-12 | 2007-04-19 | Biolipox Ab | Benzoxazoles useful in the treatment of inflammation |
ATE533485T1 (en) | 2005-10-31 | 2011-12-15 | Merck Sharp & Dohme | CETP INHIBITORS |
EP2038272B8 (en) * | 2006-06-30 | 2013-10-23 | Sunesis Pharmaceuticals, Inc. | Pyridinonyl pdk1 inhibitors |
WO2008071944A1 (en) * | 2006-12-14 | 2008-06-19 | Boehringer Ingelheim International Gmbh | Benzoxazoles useful in the treatment of inflammation |
WO2008086014A2 (en) * | 2007-01-09 | 2008-07-17 | Amgen Inc. | Bis-aryl amide derivatives useful for the treatment of cancer |
MX2011011326A (en) * | 2009-04-27 | 2012-02-13 | Elan Pharm Inc | Pyridinone antagonists of alpha-4 integrins. |
JP6037396B2 (en) | 2012-01-27 | 2016-12-07 | 国立大学法人富山大学 | Serine racemase inhibitor |
KR102202242B1 (en) | 2014-04-29 | 2021-01-13 | 에프엠씨 코포레이션 | Pyridazinone herbicides |
CN104529729B (en) * | 2014-12-31 | 2016-03-30 | 浙江永太科技股份有限公司 | The preparation method of the fluoro-3-chlorobenzaldehyde of a kind of 2- |
CA3003419C (en) | 2015-10-28 | 2023-01-24 | Thomas Martin Stevenson | Novel pyridazinone herbicides |
US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
CN110291073A (en) | 2016-12-13 | 2019-09-27 | 贝塔医疗私人有限公司 | Heparanase inhibitors and application thereof |
EP3381908A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | 2-(4-(4-(bromo-methoxybenzamido)benzylamino)phenyl)benzazole derivatives and their use as anti-heparanase |
EP3381907A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Symmetrical 2-aminophenyl-benzazolyl-5-acetate compounds and their use as anti-heparanase |
TWI785022B (en) | 2017-03-28 | 2022-12-01 | 美商富曼西公司 | Novel pyridazinone herbicides |
US11548867B2 (en) | 2017-07-19 | 2023-01-10 | Idea Ya Biosciences, Inc. | Amido compounds as AhR modulators |
KR102064611B1 (en) | 2017-10-13 | 2020-01-09 | 이화여자대학교 산학협력단 | Benzoxazole derivatives, method for preparing the same and pharmaceutical composition comprising the same |
JP7556584B2 (en) * | 2019-11-18 | 2024-09-26 | ワイジェイ セラピューティクス インコーポレイテッド | Composition for treating spinal cord injury comprising stem cells treated with a novel compound |
WO2021116820A1 (en) * | 2019-12-10 | 2021-06-17 | Aurobindo Pharma Limited | An improved process for the preparation of benoxaprofen |
CN117924386B (en) * | 2023-12-22 | 2024-07-12 | 合肥综合性国家科学中心大健康研究院 | HPA1 degradation agent and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3267081A (en) * | 1962-09-19 | 1966-08-16 | Koppers Co Inc | Benzothiazole dicarboxylic acids and polymers derived therefrom |
GB1435721A (en) * | 1972-05-18 | 1976-05-12 | Lilly Industries Ltd | Benzoxazole derivatives |
JPS4943974A (en) * | 1972-09-06 | 1974-04-25 | ||
DE3443594A1 (en) * | 1984-11-29 | 1986-05-28 | Bayer Ag, 5090 Leverkusen | AMINOPHENYLBENZTHIAZOLE |
US4659360A (en) * | 1984-11-30 | 1987-04-21 | Fmc Corporation | Plant growth and development modification using benzoxazole derivatives |
WO2002060374A2 (en) * | 2001-01-29 | 2002-08-08 | Insight Strategy And Marketing Ltd | Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
-
2003
- 2003-11-17 AU AU2003283597A patent/AU2003283597A1/en not_active Abandoned
- 2003-11-17 WO PCT/GB2003/004991 patent/WO2004046122A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004046122A3 (en) | 2004-07-15 |
WO2004046122A2 (en) | 2004-06-03 |
AU2003283597A8 (en) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003283597A1 (en) | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors | |
TWI350285B (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
ZA200501677B (en) | Hydantoin derivatives and their use as TACE inhibitors. | |
EP1482944A4 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
IL176478A0 (en) | Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme | |
IL173935A0 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
HK1090359A1 (en) | Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators | |
AU2002228317A1 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
ZA200410054B (en) | Propionic acid derivatives and their use as hPPARsactivators. | |
AU2003302238A1 (en) | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors | |
AU2003250475A1 (en) | 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors | |
AU2003205558A1 (en) | Thioibotenic acid and derivatives thereof | |
PL376363A1 (en) | Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists | |
AU2003253149A1 (en) | 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors | |
AU2003285498A1 (en) | Benzoxazole, benzthiazole and benzimidazole derivatives useful as heparanase inhibitors | |
AU2003258942A1 (en) | Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors | |
AU2002230056A1 (en) | Indole derivatives and their uses as heparanase inhibitors | |
AU2003277878A1 (en) | Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors | |
AU2003269001A8 (en) | Derivatives of uronic (alkyl-d-mannopyranoside) acid, methods for the preparation thereof, and applications thereof | |
SI1487802T1 (en) | 2,3-Diaryl-pyrazolidine derivatives as neurotensin degrading enzyme inhibitors | |
AU2003232362A1 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
AU2002235899A1 (en) | Benzimidazole derivatives, method for their production and use thereof as tryptase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |